Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,198.00    -18.00 (-0.81%)
Bid:
2,188.00
Ask:
2,198.00
Spread: 10.00 (0.457%)
Market Cap: £1.46b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

12 Sep 2019 14:59

RNS Number : 1736M
Genus PLC
12 September 2019
Β 

12 September 2019

Β 

Genus plc

Β 

Director/PDMR Shareholding

Β 

Genus plc (LSE: GNS) announces that on 11 September 2019, conditional nil-cost share options were granted under the Genus 2014 Performance Share Plan over ordinary shares in Genus to an Executive Director and members of the Genus Executive Leadership Team ('GELT') as listed in table A below. In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ending 30 June 2019, nil-cost share options were granted over ordinary shares under Genus's Deferred Share Bonus Plan as listed in table B below.

Details of the performance conditions that apply to the nil-cost share options can be found in the Directors' Remuneration Report of the Genus 2019 Annual Report.

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the nil-cost share option awards made on 11 September 2019.

Β 

For further information please contact:

Β 

Genus:

Vaughn Walton, Deputy Company Secretary Tel: +44 (0)1256 347100

Β 

Table A - GELT 2014 Performance Share Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Bill Christianson

3. Nate Zwald

4. Jerry Thompson

5. Dr Elena Rice

6. Angelle Rosata

7. Dan Hartley

2.

Reason for the notification

a.

Position/status

1. Group Finance Director

2. Chief Operating Officer Genus PIC

3. Chief Operating Officer Genus ABS Dairy

4. Chief Operating Officer Genus ABS Beef

5. Chief Scientific Officer & Head of R&D

6. Group Human Resources Director

7. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

Β 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

Β 

Β 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under the Genus plc 2014 Performance Share Plan over ordinary shares in Genus.

Β 

c.

Price(s) and volume(s)

Numbers 1 to 7 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

Β 

Price(s)

Β 

Volume(s)

1. 2,832p

41,666

2. 2,832p

17,682

3. 2,832p

14,892

4. 2,832p

14,806

5. 2,832p

15,450

6. 2,832p

14,163

7. 2,832p

14,512

d.

Aggregated information

Β·; Aggregated volume

Β·; Price

Β 

Β 

Β 

n/a

Β 

e.

Date of the transaction

2019-09-11

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

Β 

Β 

Table B - GELT Deferred Share Bonus Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Bill Christianson

3. Nate Zwald

4. Jerry Thompson

5. Angelle Rosata

6. Dan Hartley

Β 

2.

Reason for the notification

a.

Position/status

1. Group Finance Director

2. Chief Operating Officer Genus PIC

3. Chief Operating Officer Genus ABS Dairy

4. Chief Operating Officer Genus ABS Beef

5. Group Human Resources Director

6. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

Β 

Β 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Genus's Deferred Share Bonus Plan following the compulsory deferral of 25% of annual bonus in respect of bonuses earned in the financial year ending 30 June 2019. For Stephen Wilson, Dan Hartley and Bill Christianson the nil-cost share options granted under Genus's Deferred Share Bonus Plan include an additional amount of 40%, 40% and 30% of salary respectively following achievement of Company milestones during the financial year ending 30 June 2019.

Β 

c.

Price(s) and volume(s)

Numbers 1 to 7 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

Β 

Price(s)

Β 

Volume(s)

1. 2,832p

7,382

2. 2,832p

4,420

3. 2,832p

1,142

4. 2,832p

1,255

5. 2,832p

895

6. 2,832p

4,704

d.

Aggregated information

Β·; Aggregated volume

Β·; Price

Β 

Β 

Β 

n/a

e.

Date of the transaction

2019-09-11

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHUUVORKBAKAAR
Date   Source Headline
8th Mar 20221:13 pmRNSNotification of Major Holdings
24th Feb 20227:00 amRNSCollaboration between PIC and Olymel LP in Canada
24th Feb 20227:00 amRNSInterim Results
1st Feb 20224:57 pmRNSBlock listing Interim Review
4th Jan 20229:47 amRNSTotal Voting Rights
26th Nov 202110:18 amRNSDisclosure of Rights Attached to Equity Shares
24th Nov 20215:51 pmRNSDirector/PDMR Shareholding
24th Nov 20212:47 pmRNSResult of AGM
24th Nov 20212:30 pmRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSAGM Trading Update
10th Nov 20212:28 pmRNSNotification of Major Holdings
15th Oct 20217:00 amRNSAnnual Report and Annual General Meeting
13th Oct 20215:56 pmRNSDirector/PDMR Shareholding
1st Oct 20213:58 pmRNSTotal Voting Rights
30th Sep 20219:59 amRNSDirector Declaration
29th Sep 20212:59 pmRNSNotification of Major Holdings
15th Sep 20214:45 pmRNSDirector/PDMR Shareholding
14th Sep 20214:32 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSPreliminary Results
1st Sep 20212:05 pmRNSTotal Voting Rights
2nd Aug 20214:00 pmRNSBlock listing Interim Review
2nd Aug 202110:09 amRNSTotal Voting Rights
1st Jul 20214:39 pmRNSTotal Voting Rights
28th Jun 20215:00 pmRNSPIC AND SERGAL ENTER INTO STRATEGIC RELATIONSHIP
22nd Jun 20217:00 amRNSCapital Markets Event & PRRSv Programme Update
14th Jun 20213:01 pmRNSNotification of Major Holdings
7th Jun 202110:42 amRNSApplication For Additional Listing
4th Jun 20214:38 pmRNSNotification of Major Holdings
17th May 20211:23 pmRNSNotification of Major Holdings
13th May 202110:50 amRNSDirector/PDMR Shareholding
9th Apr 20214:10 pmRNSDirector/PDMR Shareholding
6th Apr 20216:00 pmRNSDirector/PDMR Shareholding
1st Apr 20215:49 pmRNSTotal Voting Rights
31st Mar 20212:59 pmRNSDirector/PDMR Shareholding
22nd Mar 20217:00 amRNSBoard Changes
19th Mar 202112:20 pmRNSDirector/PDMR Shareholding
9th Mar 20215:41 pmRNSNotification of Major Holdings
3rd Mar 20215:19 pmRNSDirector/PDMR Shareholding
26th Feb 202112:39 pmRNSDirector/PDMR Shareholding
25th Feb 20217:00 amRNSInterim Results
1st Feb 202111:08 amRNSBlock listing Interim Review
1st Feb 202111:08 amRNSTotal Voting Rights
18th Jan 20217:00 amRNSTrading Update
2nd Dec 20205:44 pmRNSDirector/PDMR Shareholding
25th Nov 20201:13 pmRNSResult of AGM
25th Nov 20207:00 amRNSAGM Trading Update - Strong Performance Continues
11th Nov 20201:03 pmRNSNOTIFICATION OF MAJOR HOLDINGS
16th Oct 20208:00 amRNSAnnual Report and Annual General Meeting
1st Oct 20203:45 pmRNSTotal Voting Rights
25th Sep 20206:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.